P2-06-22: PreciseBreast, an AI-enabled digital test predicting breast cancer recurrence is equivalent with Oncotype in an observational, retrospective study of patients from Baptist Health Miami Cancer Institute in partnership with COTA, Inc. Read More
P3-03-20: A multicenter retrospective review of clinical-pathological characteristics associated with survival outcomes in a large cohort of metaplastic breast cancer patients Read More
A retrospective, descriptive analysis of a single-center experience with patients with metaplastic breast cancer. Read More
Outcomes among Hispanic metastatic breast cancer patients treated with alpelisib and fulvestrant: Single institution retrospective study. Read More
Abstract 967: Real-world transcriptomic biomarkers as replacement for immunohistochemistry and FISH studies in breast cancer Read More
Real-World Study of First-Line Treatment Patterns in HR+/HER2- Metastatic Breast Cancer (MBC) at a Tertiary Care Cancer Institute Read More
Abstract P6-08-11: Hyperglycemia in Hispanic MBC patients treated with alpelisib: single institution retrospective study Read More
Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists Read More
Abstract P4-14-05: Confirmation of the TAILORx 21-gene expression trial using a real world observational database Read More
Utilization of a Precise, Clinically Relevant, Digital Classification System to Identify Variation in Care and Costs Among Patients with Breast Cancer Read More
